BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 123 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,858,000 | +42.8% | 293,567 | -0.5% | 0.00% | 0.0% |
| Q3 2016 | $1,301,000 | +64.7% | 295,020 | +6.1% | 0.00% | +100.0% |
| Q2 2016 | $790,000 | +6.8% | 278,020 | +6.3% | 0.00% | 0.0% |
| Q1 2016 | $740,000 | -72.2% | 261,537 | +1.5% | 0.00% | -66.7% |
| Q4 2015 | $2,659,000 | -9.5% | 257,682 | +0.0% | 0.00% | -25.0% |
| Q3 2015 | $2,938,000 | -29.3% | 257,680 | -7.4% | 0.00% | -20.0% |
| Q2 2015 | $4,156,000 | +102.6% | 278,397 | +22.6% | 0.01% | +66.7% |
| Q1 2015 | $2,051,000 | -24.8% | 227,135 | +1.2% | 0.00% | -25.0% |
| Q4 2014 | $2,728,000 | +23.1% | 224,364 | -1.0% | 0.00% | +33.3% |
| Q3 2014 | $2,216,000 | -22.6% | 226,575 | +0.9% | 0.00% | -25.0% |
| Q2 2014 | $2,863,000 | – | 224,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |